2012
DOI: 10.1016/j.pt.2011.10.006
|View full text |Cite
|
Sign up to set email alerts
|

The contribution of Plasmodium chabaudi to our understanding of malaria

Abstract: Malaria kills close to a million people every year, mostly children under the age of five. In the drive towards the development of an effective vaccine and new chemotherapeutic targets for malaria, field-based studies on human malaria infection and laboratory-based studies using animal models of malaria offer complementary opportunities to further our understanding of the mechanisms behind malaria infection and pathology. We outline here the parallels between the Plasmodium chabaudi mouse model of malaria and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
159
0
5

Year Published

2013
2013
2021
2021

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 163 publications
(166 citation statements)
references
References 105 publications
2
159
0
5
Order By: Relevance
“…Tolerance almost certainly occurs in patients from holoendemic areas of malaria that do not exhibit the signs and symptoms of the disease despite the presence of blood parasites (41,42). Likewise, body temperature and weight are normalized after the control of acute parasitemia in PcAS-infected mice (5). In agreement with the concept that stimulatory and regulatory molecular pathways coexist during PcAS malaria, CD4…”
Section: Discussionsupporting
confidence: 60%
See 1 more Smart Citation
“…Tolerance almost certainly occurs in patients from holoendemic areas of malaria that do not exhibit the signs and symptoms of the disease despite the presence of blood parasites (41,42). Likewise, body temperature and weight are normalized after the control of acute parasitemia in PcAS-infected mice (5). In agreement with the concept that stimulatory and regulatory molecular pathways coexist during PcAS malaria, CD4…”
Section: Discussionsupporting
confidence: 60%
“…Among them, Plasmodium chabaudi infection is a feasible model to study strain-specific and strain-transcending immunity because of the variety of well-characterized parasite clones and the similarities to the human disease caused by Plasmodium falciparum (5). Reinfection with homologous P. falciparum parasites in humans or P. chabaudi in mice results in significant parasite control, whereas limited protection to heterologous secondary infections has been observed in both cases (3,(6)(7)(8).…”
mentioning
confidence: 99%
“…At least in our experiments, the most severe anemia following treatment occurred when resistant parasites were at frequencies of 0.01% or lower when treatment began (Figure 4). Of course P. falciparum in people and P. chabaudi in laboratory mice are not the same, 16,33 not least because the mice in these experiments were naïve to malaria infections, perhaps giving the relapsing resistant clone an advantage it would not have in a semi-immune host. Nevertheless, it is intriguing that the relapses we saw occurred 7-10 days posttreatment, which, scaling the 24-hour life cycle of P. chabaudi to the 48-hour life cycle of P. falciparum, is suggestively similar to the 14-42 days seen in relapsing P. falciparum infections.…”
Section: Discussionmentioning
confidence: 98%
“…is a natural rodent pathogen that allows for the study of the blood stage of malaria in C57BL/6 mice (29). Previous studies using the P. chabaudi model of malaria infection in mice demonstrate that Ab responses to a secondary unrelated Ag (e.g., of NP-chicken gamma globulin [CGG]) are of a lower avidity when injection occurred at the same time as infection and that P. chabaudi infection had no effect on an already established humoral memory response to the secondary Ag (30,31).…”
mentioning
confidence: 99%